中文 | English
Return
Total: 17 , 1/2
Show Home Prev Next End page: GO
Author:( Yiqiao ZHANG)

1.Therapeutic effect of hyperxia liquid on posttraumatic optic nerve injuries

Junfeng ZHANG ; Anhuai YANG ; Yiqiao XING ; Ming AI

Chinese Journal of Trauma 1990;0(04):-

2.OTX008 inhibits retinal neovascularization in oxygen-induced retinopathy mice

Ning YANG ; Wenxi ZHANG ; Tao HE ; Yiqiao XING

Chinese Journal of Ocular Fundus Diseases 2017;33(2):181-185

3.Effect of miR-513a-5p on etoposide-stimulating B7-H1 expression in retinoblastoma cells.

Li, WU ; Zhen, CHEN ; Jian, ZHANG ; Yiqiao, XING

Journal of Huazhong University of Science and Technology (Medical Sciences) 2012;32(4):601-6

4.Insights on further reforming the business model of the hospital

Junzhang TIAN ; Yiqiao ZHAO ; Gangqing ZHANG ; Yajie HUANG

Chinese Journal of Hospital Administration 2012;28(2):87-90

5.Research on Status and Pushing Approach of Credibility of the Third-party Mediation in Medical Disputes

Xiaoli ZHANG ; Shuhua CHEN ; Desheng YANG ; Yiqiao ZHAO

Chinese Medical Ethics 2017;30(8):960-962,967

6.Effect of silencing ACAT1 gene by RNA interference on proliferation, migration and invasion of human colon cancer cells

Xin CHEN ; Huiling LIANG ; Ximing XU ; Yiqiao ZHANG ; Neng CHEN ; Dandan LIN ; Ling FENG ; Yongbin ZHENG

The Journal of Practical Medicine 2017;33(7):1074-1077

7.Effect of miR-513a-5p on etoposide-stimulating B7-H1 expression in retinoblastoma cells.

Li WU ; Zhen CHEN ; Jian ZHANG ; Yiqiao XING

Journal of Huazhong University of Science and Technology (Medical Sciences) 2012;32(4):601-606

8.GC-MS method for the determination of the genotoxic impurity chlorocyclohexane in trihexyphenidyl hydrochloride bulk drug

Lining YIN ; Yu ZHANG ; Yiqiao HU ; Xin' ; an ZHAN

Journal of China Pharmaceutical University 2022;53(1):79-85

9.Survival rate change of retinal ganglion cells following optic nerve injuries in mice

Ning YANG ; Ningzhi ZHANG ; Junxue HE ; Yiqiao XING

Chinese Journal of Trauma 2021;37(12):1135-1140

10.Camrelizumab, apatinib, nab-paclitaxel, and S-1 in combination for the conversion therapy of advanced gastric cancer

Wei DENG ; Yiqiao ZHANG ; Chao JING ; Xiaobao YANG ; Zhigang BAI ; Jun ZHANG

International Journal of Surgery 2022;49(4):242-247,F4

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 17 , 1/2 Show Home Prev Next End page: GO